<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1684-1824</journal-id>
<journal-title><![CDATA[Revista Médica Electrónica]]></journal-title>
<abbrev-journal-title><![CDATA[Rev.Med.Electrón.]]></abbrev-journal-title>
<issn>1684-1824</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Ciencias Médicas de Matanzas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1684-18242018000601835</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Marcadores lipídicos en suero y síndrome coronario agudo en pacientes egresados del servicio de cardiología. Hospital Faustino Pérez]]></article-title>
<article-title xml:lang="en"><![CDATA[Lipid markers in serum and acute coronary syndrome in patients discharged from service of cardiology. Hospital Faustino Pérez]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Linares Morera]]></surname>
<given-names><![CDATA[Anmy]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vidal Casal]]></surname>
<given-names><![CDATA[Javier]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vidal Tallet]]></surname>
<given-names><![CDATA[Lázaro Arturo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martínez Fadraga]]></surname>
<given-names><![CDATA[Yuleimy]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Santos Muñoz]]></surname>
<given-names><![CDATA[Leidy]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Trimiño Galindo]]></surname>
<given-names><![CDATA[Leydiana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Clínico Quirúrgico Universitario Faustino Pérez Hernández  ]]></institution>
<addr-line><![CDATA[ Matanzas]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Universitario Pediátrico Eliseo Noel Camaño  ]]></institution>
<addr-line><![CDATA[ Matanzas]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad de Ciencias Médicas de Matanzas  ]]></institution>
<addr-line><![CDATA[ Matanzas]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Hospital Militar Universitario Dr. Mario Muñoz Monroy  ]]></institution>
<addr-line><![CDATA[ Matanzas]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2018</year>
</pub-date>
<volume>40</volume>
<numero>6</numero>
<fpage>1835</fpage>
<lpage>1855</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1684-18242018000601835&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1684-18242018000601835&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1684-18242018000601835&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  las enfermedades cardiovasculares actualmente son la principal causa de muerte en los países industrializados y se espera que también lo sean en los países en vías de desarrollo en el año 2020. Entre ellas la enfermedad arterial coronaria es la manifestación más prevalente, y se asocia a alta morbimortalidad. La ateroesclerosis es su principal génesis y por tanto los trastornos del metabolismo de los lípidos.  Objetivo: determinar el perfil lipídico en pacientes egresados por síndrome coronario agudo.  Materiales y métodos:  se realizó una investigación descriptiva, transversal, correlacional en los pacientes egresados del servicio de cardiología del hospital Faustino Pérez en el período comprendido entre enero y diciembre del 2015.  Resultados:  se observó un aumento de los lípidos colesterol, triglicéridos, LDL-c, VLDL y Lp (a) en más del 50% de los pacientes estudiados. Los índices de Apo B/Apo A y Col/HDL-c marcaron como indicador de alto riesgo en un 67,5 y 58,75 % respectivamente. La HDL-c considerada como factor protector, resultó disminuida en más del 50% de los pacientes.  Conclusiones:  se detectó correlación entre el síndrome coronario agudo y trastornos en el metabolismo de los lípidos. Se recomienda realizar estudios observacionales epidemiológicos para determinar la verdadera influencia de estos factores como agente causal de síndrome coronario agudo.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  Currently, cardiovascular diseases are the main cause of death in developed countries, and it is believed that they also will be the same in developing countries in 2020 year. Among them, coronary arterial disease is the most prevalent manifestation, and is associated to high morbi-mortality. Atherosclerosis is its most important cause and consequently the disorders of the lipids metabolism.  Objective: determining the lipid profile in patients discharged for acute coronary syndrome.  Materials and methods:  a descriptive, cross-sectional, correlational research was carried out in patients discharged from the service of Cardiology of the hospital Faustino Perez in the period from January to December 2015.  Results:  it was found an increase of the lipids cholesterol, triglycerides, LDL-c, VLDL and Lp(a) in more than 50 % of the studied patients. The indexes of Apo B/Apo A and Col/HDL-c were high risk indicators in 67.5 and 58.75 % respectively. HDL-c, considered as a protecting factor, was diminished in more than 50 % of the patients.  Conclusions:  a correlation was found between the acute coronary syndrome and disturbances in the lipids metabolism. We recommend performing epidemiologic, observational studies to determine the real influence of these factors as causal agent of the acute coronary syndrome.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[enfermedad arterial coronaria]]></kwd>
<kwd lng="es"><![CDATA[ateroesclerosis]]></kwd>
<kwd lng="es"><![CDATA[perfil lipídico]]></kwd>
<kwd lng="es"><![CDATA[síndrome coronario agudo.]]></kwd>
<kwd lng="en"><![CDATA[coronary arterial disease]]></kwd>
<kwd lng="en"><![CDATA[atherosclerosis]]></kwd>
<kwd lng="en"><![CDATA[lipid profile]]></kwd>
<kwd lng="en"><![CDATA[acute coronary syndrome.]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<collab>Comité de la ESC para la Práctica de las Guías (CPG)</collab>
<article-title xml:lang=""><![CDATA[Guía práctica clínica de ESC para el manejo de síndrome coronario agudo de pacientes sin elevación persistente del segmento St]]></article-title>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2012</year>
<volume>65</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>173.e1-e55</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Timmis]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Townsend]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Gale]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[ESC Scientific Document Group. European Society of Cardiology: Cardiovascular Disease Statistics 2017]]></article-title>
<source><![CDATA[EurHeart J]]></source>
<year>2018</year>
<volume>39</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>508-79</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Elosua]]></surname>
<given-names><![CDATA[IR]]></given-names>
</name>
<name>
<surname><![CDATA[Morales Salinas]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Determinación del riesgo cardiovascular total. Caracterización, modelización y objetivos de la prevención según el contexto sociogeográfico]]></article-title>
<source><![CDATA[Rev Cubana de Cardiología y Cirugía Cardiovascular]]></source>
<year>2011</year>
<volume>17</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1561-2937</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Albert]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pathological and clinical manifestations of acute myocardial infarction]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Braunwald]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<source><![CDATA[Heart disease]]></source>
<year>1998</year>
<page-range>1309-45</page-range><publisher-loc><![CDATA[Philadelphia ]]></publisher-loc>
<publisher-name><![CDATA[WB Saunders]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nichols]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Townsend]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Scarborough]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardiovascular disease in Europe 2014: epidemiological update]]></article-title>
<source><![CDATA[Eur Heart J]]></source>
<year>2014</year>
<volume>35</volume>
<numero>42</numero>
<issue>42</issue>
<page-range>2950</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<collab>GBD 2013 Mortality and Causes of Death Collaborators</collab>
<article-title xml:lang=""><![CDATA[Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013]]></article-title>
<source><![CDATA[The Lancet]]></source>
<year>2015</year>
<volume>385</volume>
<numero>9963</numero>
<issue>9963</issue>
<page-range>117-71</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yusuf]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Hawken]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ounpuu]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2014</year>
<volume>364</volume>
<numero>9438</numero>
<issue>9438</issue>
<page-range>937-52</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cordero]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Moreno-Arribas]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bertomeu-Gonzalez]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Los niveles bajos de colesterol HDL se asocian de forma independiente a enfermedad coronaria aguda en pacientes que ingresan por dolor torácico]]></article-title>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2012</year>
<volume>65</volume>
<page-range>319-25</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thompson]]></surname>
<given-names><![CDATA[WG]]></given-names>
</name>
<name>
<surname><![CDATA[Gau]]></surname>
<given-names><![CDATA[GT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hypertriglyceridemia and its pharmacologic treatment among US adults-invited commentary]]></article-title>
<source><![CDATA[Arch Intern Med]]></source>
<year>2012</year>
<volume>169</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>578-9</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sprecher]]></surname>
<given-names><![CDATA[DL]]></given-names>
</name>
<name>
<surname><![CDATA[Pearce]]></surname>
<given-names><![CDATA[GL]]></given-names>
</name>
<name>
<surname><![CDATA[Cosgrove]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Relation of serum triglyceride levels to survival after coronary artery bypass grafting]]></article-title>
<source><![CDATA[Am J Cardiol]]></source>
<year>2012</year>
<volume>86</volume>
<page-range>285</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[Min]]></given-names>
</name>
<name>
<surname><![CDATA[Hu]]></surname>
<given-names><![CDATA[Xiaolan]]></given-names>
</name>
<name>
<surname><![CDATA[Fan]]></surname>
<given-names><![CDATA[Yingli]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hyperuricemia and the risk for coronary heart disease morbidity and mortality a systematic review and dose-response meta-analysis]]></article-title>
<source><![CDATA[Scientific Reports]]></source>
<year>2016</year>
<volume>6</volume>
<numero>19520</numero>
<issue>19520</issue>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Per]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Jakobsen]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Predictors for major cardiovascular outcomes in stable ischemic heart disease (PREMAC)]]></article-title>
<source><![CDATA[Diagnostic and Prognostic Research]]></source>
<year>2017</year>
<volume>1</volume>
<numero>10</numero>
<issue>10</issue>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Patel]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Winkel]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ali]]></surname>
<given-names><![CDATA[MK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardiovascular mortality associated with 5 leading risk factors: national and state preventable fractions estimated from survey data]]></article-title>
<source><![CDATA[Ann Intern Med]]></source>
<year>2015</year>
<volume>163</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>245-53</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Van Linthout]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Spillmann]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Riad]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Human apolipoprotein A-I gene transfer reduces the development of experimental diabetic cardiomyopathy]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2008</year>
<volume>117</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1563-73</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nakamura]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Kawai]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparación del ataque coronario agudo entre hospitales de Japón y Norte América]]></article-title>
<source><![CDATA[Int J Cardiol]]></source>
<year>2003</year>
<volume>7</volume>
<numero>21</numero>
<issue>21</issue>
<page-range>245-54</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alexander]]></surname>
<given-names><![CDATA[JK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Obesity and coronary heart disease Department of Medicine Houston Texas USA]]></article-title>
<source><![CDATA[Am J Med Sci]]></source>
<year>2012</year>
<volume>321</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>215-24</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
